Journal of general internal medicine
-
Randomized Controlled Trial
Blood Pressure Visit Intensification in Treatment (BP-Visit) Findings: a Pragmatic Stepped Wedge Cluster Randomized Trial.
Shortening time between office visits for patients with uncontrolled hypertension represents a potential strategy for improving blood pressure (BP). ⋯ www.ClinicalTrials.gov Identifier: NCT02164331.
-
Randomized Controlled Trial
Impact of Metformin on Statin Persistence: a Post Hoc Analysis of a Large Randomized Controlled Trial.
-
Randomized Controlled Trial
The Coordination Toolkit and Coaching Project: Cluster-Randomized Quality Improvement Initiative to Improve Patient Experience of Care Coordination.
Given persistent gaps in coordination of care for medically complex primary care patients, efficient strategies are needed to promote better care coordination. ⋯ Although coached clinics attempted more or more complex QI projects and used more tools than non-coached clinics, coaching provided no additional benefit versus the online toolkit alone in patient-reported outcomes.
-
Randomized Controlled Trial
Computerized Relational Agent to Deliver Alcohol Brief Intervention and Referral to Treatment in Primary Care: a Randomized Clinical Trial.
Alcohol screening and brief intervention have demonstrated efficacy but limited effectiveness and implementation in real-world primary care settings. ⋯ The Relational Agent successfully provided brief intervention and referred many more patients to specialty care and was able to intervene with patients with less severe drinking without increasing primary care burden.
-
Randomized Controlled Trial
Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID).
Colchicine is an available, safe, and effective anti-inflammatory drug and has been suggested as a COVID-19 treatment, but its usefulness in hospitalized severe COVID-19 patients has not been thoroughly demonstrated. ⋯ Colchicine is safe but not effective in the treatment of severe COVID-19.